Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-002673
Filing Date
2025-03-11
Accepted
2025-03-11 15:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27728
2 filename2.txt TEXT-EXTRACT 1207
  Complete submission text file 0000000000-25-002673.txt   40074
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filed for) CIK: 0001867096 (see all company filings)

EIN.: 871082097 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-285597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)